Hinge Health (NYSE:HNGE) Shares Up 6.5% - Here's What Happened

Hinge Health, Inc. (NYSE:HNGE - Get Free Report) shares shot up 6.5% on Tuesday . The stock traded as high as $39.00 and last traded at $38.55. 498,971 shares traded hands during mid-day trading, a decline of 37% from the average session volume of 794,916 shares. The stock had previously closed at $36.21.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on HNGE. Piper Sandler began coverage on shares of Hinge Health in a research report on Monday. They issued an "overweight" rating and a $41.00 price target on the stock. Raymond James began coverage on shares of Hinge Health in a research report on Monday. They issued an "outperform" rating and a $45.00 price target on the stock. William Blair began coverage on shares of Hinge Health in a research report on Monday. They issued an "outperform" rating on the stock. Needham & Company LLC began coverage on shares of Hinge Health in a research note on Monday. They set a "buy" rating and a $47.00 price objective for the company. Finally, Morgan Stanley began coverage on shares of Hinge Health in a research note on Monday. They set an "overweight" rating and a $46.00 price objective for the company. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $46.00.

Hinge Health Stock Performance

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.